5-Amino-1MQ

5-Amino-1MQ — 50MG

5-Amino-1MQ is a small-molecule research compound primarily investigated for its interaction with nicotinamide N-methyltransferase (NNMT), an enzyme involved in nicotinamide metabolism and cellular metabolic regulation. Unlike peptide-based research compounds, 5-Amino-1MQ is a small molecule and has primarily been evaluated in preclinical and experimental models. This product is intended exclusively for academic and laboratory research applications under appropriate regulatory oversight.

Research Context
5-Amino-1MQ has attracted research interest as an experimental NNMT inhibitor. NNMT catalyzes the methylation of nicotinamide using S-adenosylmethionine (SAM), producing 1-methylnicotinamide.
Because NNMT activity intersects with nicotinamide metabolism, methyl-donor availability, and pathways associated with cellular energy regulation, researchers have investigated whether altering NNMT activity can influence metabolic function.
Preclinical studies have also explored NNMT expression and activity in adipose tissue and other tissues, although potential therapeutic applications of 5-Amino-1MQ remain investigational.

Research Overview
Research involving 5-Amino-1MQ has primarily focused on cellular and animal models examining the biological consequences of NNMT inhibition.
Experimental studies have investigated relationships among NNMT activity, adipose-tissue metabolism, cellular energy expenditure, and metabolic regulation. Researchers have also explored how inhibition of NNMT may affect nicotinamide-related pathways and intracellular metabolic processes.
Research into 5-Amino-1MQ remains preclinical, and findings from experimental models should not be interpreted as demonstrating safety or effectiveness for human use.
Key Research Focus Areas
NNMT Inhibition
Investigation of 5-Amino-1MQ as an experimental inhibitor of nicotinamide N-methyltransferase and the downstream biochemical consequences of altering NNMT activity.
Nicotinamide Metabolism
Study of pathways involving nicotinamide utilization, methylation, and related cellular metabolic processes.
Adipose Tissue Biology
Preclinical investigation of NNMT expression and activity within adipose tissue and its potential relationship with adipocyte metabolism and energy regulation.
Cellular Energy Metabolism
Exploration of metabolic pathways associated with energy expenditure, substrate utilization, and cellular metabolic homeostasis.
NAD-Related Metabolic Research
Investigation of the broader relationship between nicotinamide availability, NAD-associated pathways, and cellular energetics. NNMT inhibition should not, however, be assumed to directly or predictably increase NAD+ in humans.
Metabolic Regulation
Evaluation of NNMT inhibition in experimental models examining metabolic dysfunction, energy balance, and related biochemical processes.

Important Compliance and Safety Information
5-Amino-1MQ is intended solely for laboratory research and should be handled using appropriate laboratory procedures. Researchers are responsible for ensuring compliance with applicable federal, state, local, and institutional requirements governing the acquisition, storage, handling, labeling, and study of research compounds.

The safety, efficacy, pharmacokinetics, and appropriate exposure parameters of 5-Amino-1MQ for therapeutic use have not been established. It should not be represented as an approved weight-loss, fat-burning, metabolic, or therapeutic treatment based on preclinical findings.

Research findings from cellular or animal models should not be interpreted as evidence that 5-Amino-1MQ is safe or effective for human use.
For research use only.